Robb Gary Charles
Robb Gary Charles, CBO, reported an open-market or private sale at CORCEPT THERAPEUTICS INC involving 10000.000000 shares for an estimated $1162572.00. Reported holdings after the transaction were 39716.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 17, 2026
- Filing date
- Aug 18, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 49,716 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CORT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001193125-26-355560 Common Stock
- Transaction date
- Aug 17, 2026 Filed Aug 18, 2026, 08:30 PM · 1d delay
- Shares
- 10,000 sh $116.26 per share
- Estimated value
- -$1.16M Computed from shares × price
- Holdings after
- 39,716 sh Indirect · Gary Charles Robb TTE Robb Revocable Trust
Filing signal explanations
Badges describe filing facts only — not predictions.
+4 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Business Officer
- F1
Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to th…
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each…
- F3
These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
- F4F5(2 footnotes)
These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
0 other transactions
0 recent txs